share_log

Kezar Life Sciences Q4 EPS $(0.44) Misses $(0.38) Estimate

Kezar Life Sciences Q4 EPS $(0.44) Misses $(0.38) Estimate

Kezar Life Sciences第四季度每股收益美元 (0.44) 未达到预期 (0.38)
Moomoo 24/7 ·  03/14 16:04

Kezar Life Sciences (NASDAQ:KZR) reported quarterly losses of $(0.44) per share which missed the analyst consensus estimate of $(0.38) by 15.79 percent. This is a 76 percent decrease over losses of $(0.25) per share from the same period last year.

Kezar Life Sciences(纳斯达克股票代码:KZR)公布的季度亏损为每股0.44美元,比分析师普遍预期的0.38美元(0.38美元)低15.79%。这比去年同期每股亏损0.25美元(0.25美元)下降了76%。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发